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O2, 5％ CO2）で飽和した Krebs-Henseleit液（37 
± 0.1℃）を用いて Langendorff式に定圧灌流 
(75 cm H2O) を行った。灌流液の組成（mM）は、
NaCl 118，KCl 4.7，NaHCO3 4.9，MgSO4 1.18，

























NG-nitro-L-arginine（L-NNA; Sigma Chemical 
CO., St.Louis, MO, USA）を 用 い た。ま た、
PGI2 の関与を検討する目的で、シクロオキシ
ゲナーゼ阻害薬 ディクロフェナクナトリウム 

















































その結果、Diclofenac 存在下における hUTII 
（100 nmol）の冠血管拡張作用は、いずれの月
Urotensin Ⅱの冠拡張作用
　図１．冠流量（CF）に対するHuman urotensin II（hUTII, 100 nmol）の繰り返し投与の影響
縦軸：hUTII投与前のCFを100％とした。横軸：hUTII投与後の時間経過。
A : 若齢ラット、B : 老齢ラット　○１回目投与、▲２回目投与、□３回目投与。( ) 内は実験例数。
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　図２．Human urotensin II（hUTII, 100 nmol）の冠血管作用に対するL-NNAの影響
縦軸：hUTII投与前のCFを100％とした。横軸：hUTII投与後の時間経過。
A : 若齢ラット、B : 老齢ラット　○ hUTII単独、● L-NNA（10μM）存在下におけるhUTIIの作用、
* Ｐ<0.05（vs hUTII単独）。（ ）内は実験例数。
　図３．Human urotensin II（hUTII, 100 nmol）の冠血管作用に対するDiclofenacの影響
縦軸：hUTII投与前のCFを100％とした．横軸：hUTII投与後の時間経過。
A : 若齢ラット、B : 老齢ラット　○ hUTII単独、● Diclofenac（10μM）存在下におけるhUTIIの作






















































　表２．Human urotensin II（hUTII, 100nmol）の心機能に対する作用
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U rotensin II increases coronary flow 
endothelium-dependently in the perfused 
heart of young and aged Fischer 344 rats
Tomoko Ogaki, Akira Ishihata＊, Tomomi Aita, Yumi Katano
ABSTRACT
Divition of Clinical Nursing, Department of Nursing, 
 ＊Department of Physiology , Yamagata University School of
 Medicine, Yamagata,  Japan
　Urotensin II (UTII) isolated from fish neurosecretory system is a cyclic peptide 
composed of 12 amino acid residues. Human UT II (hUTII) and its receptor were 
expressed in human cardiovascular tissues. Although hUTII was reported to be a more 
potent vasoconstrictor than endothelin-1, the effect of hUTII on the mammalian heart 
and its age-related changes are not clarified yet. We studied the effect of hUTII on 
coronary circulation and its age-related changes in the young (2-3 months) and aged (27-
32 months) male Fischer 344 rats. Isolated heart was perfused at a constant pressure 
(75 cm H2O) by Langendorff's method with a Krebs-Henseleit solution (37℃, pH 7.4). 
The coronary flow was measured continuously with a flow meter. hUTII elicited a 
transient vasoconstriction and a sustained vasodilatation of coronary artery. No age-
related changes in the vasodilatation was observed. A nitric oxide (NO) synthase 
inhibitor NG-nitro-L-arginine, partially inhibited the vasodilatation in young rats, but 
not in aged rats. In the presence of a cyclooxygenase inhibitor diclofenac, hUTII-induced 
vasodilatation was abolished both in young and aged rats. hUTII stimulated the 
prostacyclin production, which was not significantly different between young and aged 
rats. hUTII slightly increased the heart rate without change in the ventricular 
contractility. These results suggest that the predominant effect of hUTII was 
endothelium-dependent coronary vasodilatation in the rats, and the vasodilatation in 
aged rats was maintained by prostacyclin.
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